Research Blog

July 16, 2015

Grant enhances mental illness drug research efforts

Research at Vanderbilt University Medical Center aimed at developing potential new treatments for major depressive disorder, general anxiety disorder and post-traumatic stress disorder got a big boost this week from The William K. Warren Foundation of Tulsa, Oklahoma.

By Bill Snyder
July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

By Bill Snyder
July 9, 2015

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

By Matt Batcheldor
Phyllis Freeman Randy Blakely Vanderbilt Lab
July 7, 2015

NSF award goes to Fisk geneticist following VU post-doc training

The partnership with Fisk through the Fisk-Vanderbilt Masters-to-PhD Bridge Program and other avenues, “presents us with an opportunity to see the results of our efforts impact an under-served community.”

By VUMC News and Communications
June 29, 2015

VUMC’s Patrick speaks to members of congress about neonatal abstinence syndrome

Stephen Patrick, M.D., MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology with the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently testified before congress about the rise in neonatal abstinence syndrome.

By VUMC News and Communications
June 25, 2015

Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

By Jessica Pasley
June 25, 2015

Grant to spur study of ‘brown fat’s’ metabolic mysteries

Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets.
By VUMC News and Communications
June 25, 2015

VEI receives grant from Research to Prevent Blindness for research and education

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.
By Jessica Pasley
June 22, 2015

Biochemistry professor Richard Armstrong remembered

Richard N. Armstrong, Ph.D., professor of Biochemistry and Chemistry, prominent biochemist, journal editor and mentor, died on June 18 after a brief illness. He was 66.
By Bill Snyder
June 17, 2015

Grant significantly expands Vanderbilt’s autism training for Tennessee educators

The Tennessee Department of Education (TDOE) has awarded a five-year, $10 million training grant to Vanderbilt Kennedy Center’s Treatment and Research Institute for Autism Spectrum Disorders (TRIAD), continuing a 16-year partnership to provide education and training opportunities for school personnel throughout the state.
By VUMC News and Communications
June 4, 2015

Dalley’s contributions to anatomical sciences recognized

Arthur Dalley, Ph.D., professor of Cell and Developmental Biology at Vanderbilt, recently received the highest education award for human anatomy education in the anatomical sciences during the 2015 Experimental Biology meeting in Boston.
By Jessica Pasley
May 14, 2015

Jansen’s cancer research efforts garner recognition

Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research.
By VUMC News and Communications
April 30, 2015

VICC cancer research efforts in spotlight at AACR conference

Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer.
By VUMC News and Communications
1 … 7 8 9 10 11 … 17